// App-Quantinova.ai

585 : Early detection of change in motor and cognitive symptoms in a longitudinal Progressive Supranuclear Palsy cohort – the OxQUIP study.

Researchers

Presenter

  • M. Pereira

Principal Investigators

  • C. Antoniades

Medical Centers

  • N/A

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Progressive supranuclear palsy

Biomarkers

  • Regenerating islet-derived 1 alpha

Drug/Treatment

  • Levodopa

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved